Showing results (181-190 of 212) with videos related to
Sort By:
Pageof 22
Cancer Research and Treatment|July 3, 2025
Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)Yoon-Koo Kang, Min-Hee Ryu, Do-Youn Oh, et al.American Journal of Hematology|February 3, 2007
Nongastric marginal zone B-cell lymphoma: analysis of 247 casesSung Yong Oh, Baek-Yeol Ryoo, Won Seog Kim, et al.American Journal of Clinical Oncology|August 2, 2002
Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancerKihyun Kim, Eunmi Nam, Nam Soo Lee, et al.Annals of Hematology|January 4, 2020
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphomaYoung-Woong Won, Hyewon Lee, Hyeon-Seok Eom, et al.American Journal of Hematology|November 6, 2009
Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 casesSung Yong Oh, Won Seog Kim, Seok Jin Kim, et al.Blood Research|April 12, 2014
Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of LymphomaByung Woog Kang, Sang Kyun Sohn, Joon Ho Moon, et al.Blood|March 12, 2025
Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell LymphomaSeok Jin Kim, Jing Quan Lim, Sang Eun Yoon, et al.Nature Cancer|March 18, 2025
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trialWon Seog Kim, Tae Min Kim, Seok-Goo Cho, et al.Cancer Letters|October 16, 2007
Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter studySung Yong Oh, Hyuk-Chan Kwon, Won Seog Kim, et al.The Oncologist|July 9, 2017
Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III TrialSe-Il Go, Dong-Hoe Koo, Seung Tae Kim, et al.Pageof 22